Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.885 USD | +3.57% | -5.08% | -87.30% |
01:29pm | Mizuho Cuts Price Target on Amylyx Pharmaceuticals to $3 From $4, Keeps Neutral Rating | MT |
May. 09 | Transcript : Amylyx Pharmaceuticals, Inc., Q1 2024 Earnings Call, May 09, 2024 |
Financials (USD)
Sales 2024 * | 99.3M | Sales 2025 * | - | Capitalization | 124M |
---|---|---|---|---|---|
Net income 2024 * | -171M | Net income 2025 * | -75M | EV / Sales 2024 * | 0.37 x |
Net cash position 2024 * | 87.38M | Net cash position 2025 * | 62.5M | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-0.72
x | P/E ratio 2025 * |
-1.7
x | Employees | 384 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 83.02% |
Latest transcript on Amylyx Pharmaceuticals, Inc.
1 day | +3.70% | ||
1 week | -8.54% | ||
Current month | +0.55% | ||
1 month | -13.33% | ||
3 months | -87.83% | ||
6 months | -85.94% | ||
Current year | -87.64% |
Managers | Title | Age | Since |
---|---|---|---|
Justin Klee
FOU | Founder | 34 | 12-12-31 |
Josh Cohen
FOU | Founder | 33 | 12-12-31 |
Jim Frates
DFI | Director of Finance/CFO | 56 | 20-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
George Milne
CHM | Chairman | 80 | 14-12-31 |
Kari Firestone
BRD | Director/Board Member | - | 23-03-15 |
Paul R. Fonteyne
BRD | Director/Board Member | 63 | 21-03-28 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.14% | 0 M€ | 0.00% | - | |
0.09% | 234 M€ | +2.60% | - | |
0.04% | 2 M€ | -.--% | ||
0.02% | 9 M€ | +9.07% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-14 | 1.89 | +3.85% | 1 060 293 |
24-05-13 | 1.82 | +3.70% | 1,351,129 |
24-05-10 | 1.755 | -7.14% | 1,590,296 |
24-05-09 | 1.89 | -2.07% | 3,284,794 |
24-05-08 | 1.93 | -2.03% | 1,514,637 |
Delayed Quote Nasdaq, May 13, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-87.64% | 124M | |
-2.47% | 89.37B | |
+2.76% | 40.65B | |
-12.92% | 32.81B | |
+52.09% | 25B | |
-16.51% | 15.29B | |
-42.60% | 11.61B | |
-12.82% | 11.49B | |
+5.09% | 8.98B | |
-7.72% | 8.23B |
- Stock Market
- Equities
- AMLX Stock